This inventor holds 1 USPTO granted patent. Top assignee: Dongkook Pharmaceutical Co., Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovator Spotlight: Goo-Young Jung and His Contributions to Sustained-Release Microcapsules
Introduction
Goo-Young Jung is an accomplished inventor based in Chungcheongbuk-do, South Korea, recognized for his innovative approach in the pharmaceutical field. His significant contributions focus on the development of sustained-release formulations that enhance the delivery of bioactive substances.
Latest Patents
Jung holds a notable patent titled "Preparation method of sustained-release microcapsules having initial burst inhibiting property and the microcapsules thereby." This patent discloses a method for preparing longer sustained-release formulations comprising bioactive substances. Specifically, the invention details a process that involves adding an emulsion containing bioactive substances, a biocompatible polymer, and polyvinylpyrrolidone to an aqueous solution, thus resulting in effective microcapsules for drug delivery.
Career Highlights
Currently, Goo-Young Jung is associated with Dongkook Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical innovations. His work has been fundamental in developing more effective treatments through advanced drug delivery systems.
Collaborations
Throughout his career, Jung has collaborated with esteemed colleagues, including Nak-Hyun Lim and Jung-Kwoun Kim. Their combined efforts have driven significant advancements in the field of pharmaceutical sciences and contributed to the success of their projects at Dongkook Pharmaceutical Co., Ltd.
Conclusion
Goo-Young Jung exemplifies the spirit of innovation through his dedication to enhancing pharmaceutical formulations. His patent reflecting a unique method for preparing sustained-release microcapsules marks a noteworthy achievement in the industry, promising better therapeutic outcomes and paving the way for future advancements in drug delivery technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile